Management of Heart Failure with Renal Artery Ischaemia
Atherosclerotic renal artery disease is often associated with disease elsewhere in the cardiovascular system. In the setting of heart failure, morbidity and mortality are significantly increased in those patients with co-existent renovascular disease. As understanding of this cardiorenal interaction evolves, it is clear that awareness and early interventions with targeted medical therapies aimed at reducing atherosclerotic burden are essential to prevent progression of renovascular disease and cardiovascular events, with further targeted revascularization possibly playing a role in appropriately selected patients. This article reviews the current diagnostic and treatment modalities for renovascular disease, as well as highlighting some of the key trials of revascularization vs. medical therapy for treatment of this condition.
KeywordsCholesterol Obesity Catheter Dioxide Filtration
- 1.Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Am J Kidney Dis. 2004;43:S101–6.Google Scholar
- 17.The ASTRAL Investigators, Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361:1953–62.Google Scholar